BioCorteX announces collaboration with Tempus to unlock the role of the bacteria in the tumour microenvironment (TME) creating personalised patient profiles. 19 August 2024 Read More
BioCorteX announces collaboration with Tempus to unlock the role of the bacteria in the tumour microenvironment (TME) creating personalised patient profiles. 19 August 2024 Read More
Bridging the gap: hidden drug bacteria interactions and addressing the inequities in cancer trials. 16 July 2024 Read More
The role of intratumoural bacteria in the Warburg effect in patients with lung cancer 5 December 2023 Read More
Differences in the intratumour microbiome of patients with colorectal cancer in Europe and Japan compared to the US. 5 December 2023 Read More
The microbiome and metabolome profile in Japan, South Korea and the USA is directly linked to filaggrin gene expression and incidence of atopic dermatitis 5 December 2023 Read More
Sequence homology of bacterial and mitochondrial genes implicated in cancer pathogenesis 5 December 2023 Read More
Assessment of the differential profile of breast intratumoral bacteria intreatment responders and non-responders 4 December 2023 Read More
